BRAF Activation by Metabolic Stress Promotes Glycolysis Sensitizing NRAS^Q61-Mutated Melanomas to Targeted Therapy

Researchers showed that NRASQ61 mutated melanomas specific metabolic settings mediated cell sensitivity to sorafenib upon metabolic stress.